Little Falls facility resumes production with FDA approval of critical pain solution Reykjavik, Iceland, 17 April 2009 — Actavis Group, the international generic pharmaceuticals company,
Tag: generic drugs
Actavis formally launched in France
Actavis in France was formally launched on 23rd October at a one-day conference held at the Centre Étoile-Saint Honoré, close to the Champs Elysées in
Actavis and Medis represented at CPhI
Actavis Group employees from diverse departments from all over the world will be present at this year’s annual CPhI conference, held in Frankfurt, Germany, 30
Actavis gets approval for generic Wellbutrin in the United States
Generic drugs company Actavis has received approval from the FDA to market Bupropion Hydrochloride extended-release tablets (XL) 300mg in the US. Actavis, a leading generic
Actavis announces senior appointments
Following Robert Wessman’s departure as CEO, a number of changes in senior management have taken place at the generic pharmaceuticals manufacturer. Actavis Group, the international
Actavis to sell chlamydia drug Clamelle without prescription in the UK
Generic pharmaceutical company Actavis will launch its first ever over the counter (OTC) oral antibiotic in the UK. Actavis, a generic drug manufacturer, has announced
Actavis first to market generic prostate cancer drug Bicalutamide in the UK, Germany & France
Actavis, the international generic pharmaceuticals company, recently launched Bicalutamide tablets in the UK, Germany and France. Acuavis Bicalutamide is the first generic version of the
Actavis supports cause of disabled access in Bulgaria
The Iceland-based generic drugs manufacturer Actavis announces the opening of a new disabled access ramp to a major Bulgarian cathedral. Actavis has financed the construction